Lee Den-Ching A, Dissanayaka Thusharika, Burton Elissa, Meyer Claudia, Hunter Susan W, Suttanon Plaiwan, Ekegren Christina L, Stout Julie C, Dawes Helen, Hill Keith D
Faculty of Medicine, Nursing and Health Sciences, School of Primary and Allied Health Care, Monash University, Frankston, Australia.
Rehabilitation Ageing and Independent Living (RAIL) Research Centre, Monash University, Frankston, Australia.
Disabil Rehabil. 2022 Oct;44(21):6139-6154. doi: 10.1080/09638288.2021.1958930. Epub 2021 Aug 10.
To integrate the evidence of gait aid prescription for improving spatiotemporal gait parameters, balance, safety, adherence to gait aid use, and reducing falls in community-dwelling older people.
Seven health databases were searched to June 2021. Experimental studies investigating gait aid prescription (provision and instruction for use) for older people, reporting gait parameters, balance, falls, and safety of or adherence to gait aid use was included. Mean differences with 95% confidence intervals of gait and balance outcomes in participants at the program's last follow-up were analyzed. The safety of and adherence to gait aid use were described.
Eight studies were included ( = 555 older people). No meta-analyses could be performed. Five studies used a single gait aid instruction session. Gait aid prescription had inconsistent effects on gait velocity, and no reported benefits in reducing gait variability in older people with mobility problems or fall risks, including Parkinson's or Alzheimer's disease. No study investigated gait aid prescription on falls and balance performance. Effects on safety and adherence to gait aid use were unclear.
Research is needed to investigate the benefits of extensive gait aid training in older people with mobility problems, including those with dementia or high falls risk.IMPLICATIONS FOR REHABILITATIONThere is little evidence currently addressing the benefits of gait aid prescription on gait and associated outcomes in older people with mobility problems or fall risks.Gait aid prescription yielded inconsistent effects on increasing gait velocity and did not appear to reduce gait variability in older people with mobility problems or fall risks, nor in those with Parkinson's disease or Alzheimer's disease.Clinicians may consider using a more extensive gait aid training approach to optimize learning of safe gait patterns and gait aid use, which may produce better outcomes.
整合关于助行器处方对改善社区居住老年人时空步态参数、平衡能力、安全性、助行器使用依从性及减少跌倒方面的证据。
检索了7个健康数据库至2021年6月。纳入了针对老年人助行器处方(提供及使用指导)的实验研究,这些研究报告了步态参数、平衡能力、跌倒情况以及助行器使用的安全性或依从性。分析了项目最后一次随访时参与者步态和平衡结果的平均差异及95%置信区间。描述了助行器使用的安全性和依从性。
纳入8项研究(n = 555名老年人)。无法进行荟萃分析。5项研究使用了单次助行器使用指导课程。助行器处方对步态速度的影响不一致,且在有行动问题或跌倒风险的老年人(包括帕金森病或阿尔茨海默病患者)中,未报告在减少步态变异性方面有任何益处。没有研究调查助行器处方对跌倒和平衡能力的影响。对助行器使用安全性和依从性的影响尚不清楚。
需要开展研究以调查针对有行动问题的老年人(包括患有痴呆症或跌倒风险高的老年人)进行广泛助行器训练的益处。
对康复的启示
目前几乎没有证据表明助行器处方对有行动问题或跌倒风险的老年人的步态及相关结果有益。
助行器处方在提高步态速度方面效果不一致,且似乎并未减少有行动问题或跌倒风险的老年人、帕金森病患者或阿尔茨海默病患者的步态变异性。
临床医生可考虑采用更广泛的助行器训练方法,以优化安全步态模式和助行器使用的学习,这可能会产生更好的效果。